+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dry Eye Medication Market by Drug Type, Product Form, Active Ingredient, Mode of Action, Distribution Channel, User Profile - Global Forecast to 2030- Product Image
Dry Eye Medication Market by Drug Type, Product Form, Active Ingredient, Mode of Action, Distribution Channel, User Profile - Global Forecast to 2030- Product Image
Sale

Dry Eye Medication Market by Drug Type, Product Form, Active Ingredient, Mode of Action, Distribution Channel, User Profile - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015548
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers navigating the dynamic ophthalmic sector are increasingly focused on how technological advancements, regulatory shifts, and evolving patient expectations impact opportunity and risk in the dry eye medication market. This concise overview equips leadership teams with the essential context and actionable perspectives necessary to guide robust market entry or expansion decisions.

Market Snapshot: Dry Eye Medication Market Size & Growth Trajectory

The dry eye medication market grew from USD 4.86 billion in 2024 to USD 5.18 billion in 2025. Continued expansion is expected at a CAGR of 6.72%, reaching USD 7.19 billion by 2030. This growth reflects mounting prevalence linked to aging populations, environmental stressors, and increased device usage. Market development remains shaped by evolving clinical practices, regulatory attention, and a broadening set of therapeutic options for mild to severe disease.

Scope & Segmentation

This report delivers a comprehensive assessment of product, technology, patient, and geographic dynamics:

  • Drug Type: Over-the-counter medication, prescription medication.
  • Product Form: Eye drops, eye lid wipes, gels, ointments, sprays.
  • Active Ingredient: Carboxymethylcellulose, cyclosporine, lifitegrast, polyethylene glycol.
  • Mode of Action: Anti-inflammatory agents, immunomodulatory agents, lubricating agents, secretagogues.
  • Distribution Channel: Hospital pharmacies, online/e-commerce platforms, retail pharmacies.
  • User Profile: Adults, geriatrics, pediatrics.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, and others).
  • Company Profiles: In-depth review of AbbVie Inc., Alcon Inc., Astellas Pharma Inc., Bausch + Lomb Corporation, and 21 additional manufacturers, innovators, and key partners.

Key Takeaways for Decision-Makers

  • Immunomodulatory agents and secretagogues are broadening therapeutic options, driving clinical differentiation alongside well-established lubricants.
  • Patient-centric care models are gaining traction, with telemedicine and digital adherence programs facilitating engagement and ongoing therapy management.
  • Strategic collaborations between biotech innovators and global pharmaceutical companies are accelerating product pipelines and promoting diversified portfolios.
  • Agile supply chain management, especially through local manufacturing partnerships, is increasingly critical for margin preservation and continuity of distribution.
  • Regional approaches must be tailored: developed markets emphasize value and documented outcomes, while emerging economies prioritize affordability and supply reliability.

Tariff Impact and Supply Chain Considerations

The 2025 U.S. tariff increases on pharmaceutical raw materials, packaging, and certain finished goods are elevating cost pressures throughout the dry eye market. Manufacturers are actively seeking alternative suppliers, reshoring production where feasible, and renegotiating contracts to offset cost inflation and safeguard competitive positioning. These changes affect both branded and generic product economics and heighten the importance of proactive supply chain planning.

Methodology & Data Sources

This report leverages a multi-dimensional research approach. Primary research includes interviews with ophthalmology leaders, formulary decision-makers, and representatives from patient organizations, providing nuanced perspectives on current clinical needs and market drivers. Supplementary quantitative insights stem from structured surveys of pharmaceutical companies and distributors. Analysis is further validated through secondary sources, encompassing regulatory filings, clinical trial databases, and industry literature, ensuring comprehensive and reliable intelligence for the dry eye medication market.

Why This Report Matters for Senior Leaders

  • Gain a holistic view of clinical, technological, and commercial trends shaping both short-term decisions and long-term growth strategies.
  • Identify precise growth opportunities through granular market segmentation by drug class, product form, and patient demographics.
  • Understand external pressures such as tariffs and regulatory shifts for enhanced operational resilience and proactive risk mitigation.

Conclusion

This report presents an actionable synthesis of the market’s evolving landscape, preparing organizations to align investments and strategies with the most promising opportunities. Leaders can apply these insights to anticipate change, optimize portfolios, and drive sustainable growth in dry eye therapeutics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dry Eye Medication Market, by Drug Type
8.1. Introduction
8.2. Over-The-Counter Medication
8.3. Prescription Medication
9. Dry Eye Medication Market, by Product Form
9.1. Introduction
9.2. Eye Drops
9.3. Eye Lid Wipes
9.4. Gels
9.5. Ointments
9.6. Sprays
10. Dry Eye Medication Market, by Active Ingredient
10.1. Introduction
10.2. Carboxymethylcellulose
10.3. Cyclosporine
10.4. Lifitegrast
10.5. Polyethylene Glycol
11. Dry Eye Medication Market, by Mode of Action
11.1. Introduction
11.2. Anti-Inflammatory Agents
11.3. Immunomodulatory Agents
11.4. Lubricating Agents
11.5. Secretagogues
12. Dry Eye Medication Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies/E-commerce Platforms
12.4. Retail Pharmacies
13. Dry Eye Medication Market, by User Profile
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Americas Dry Eye Medication Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Dry Eye Medication Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Dry Eye Medication Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Alcon Inc.
17.3.3. Astellas Pharma Inc.
17.3.4. Bausch + Lomb Corporation
17.3.5. EyeGate Pharmaceuticals, Inc.
17.3.6. Harrow Health, Inc.
17.3.7. Johnson & Johnson Services, Inc.
17.3.8. Kala Pharmaceuticals, Inc.
17.3.9. Kowa Company, Ltd.
17.3.10. Laboratorios Sophia S.A. De C.V.
17.3.11. Merck & Co., Inc.
17.3.12. Mitotech S.A.
17.3.13. Nicox S.A.
17.3.14. Novartis AG
17.3.15. Ocugen, Inc.
17.3.16. Ocular Therapeutix, Inc.
17.3.17. Optix Pharmaceuticals, Inc.
17.3.18. Otsuka Pharmaceutical Co., Ltd.
17.3.19. Perrigo Company plc
17.3.20. Pfizer Inc.
17.3.21. Rohto Pharmaceutical Co., Ltd.
17.3.22. Santen Pharmaceutical Co., Ltd.
17.3.23. Sun Pharmaceutical Industries Ltd.
17.3.24. Takeda Pharmaceutical Company Limited
17.3.25. Viatris Inc.
17.3.26. Wockhardt Ltd. by Dr. Reddy's Laboratories
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRY EYE MEDICATION MARKET MULTI-CURRENCY
FIGURE 2. DRY EYE MEDICATION MARKET MULTI-LANGUAGE
FIGURE 3. DRY EYE MEDICATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRY EYE MEDICATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRY EYE MEDICATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRY EYE MEDICATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRY EYE MEDICATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRY EYE MEDICATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY OVER-THE-COUNTER MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY PRESCRIPTION MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY EYE LID WIPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY CYCLOSPORINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY LIFITEGRAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY IMMUNOMODULATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY LUBRICATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY SECRETAGOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ONLINE PHARMACIES/E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRY EYE MEDICATION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 52. CANADA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 54. CANADA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 55. CANADA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 56. CANADA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. CANADA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 60. MEXICO DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 61. MEXICO DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. MEXICO DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES DRY EYE MEDICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 84. CHINA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 85. CHINA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 86. CHINA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 87. CHINA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 88. CHINA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. CHINA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 90. INDIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 92. INDIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 93. INDIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 94. INDIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. INDIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 102. JAPAN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 104. JAPAN DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 105. JAPAN DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. JAPAN DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 138. THAILAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 140. THAILAND DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 141. THAILAND DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. THAILAND DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRY EYE MEDICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 159. DENMARK DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 160. DENMARK DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. DENMARK DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 165. EGYPT DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 166. EGYPT DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. EGYPT DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 171. FINLAND DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 172. FINLAND DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. FINLAND DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 177. FRANCE DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 178. FRANCE DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. FRANCE DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 181. GERMANY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 183. GERMANY DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 184. GERMANY DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 193. ITALY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 194. ITALY DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 195. ITALY DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 196. ITALY DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 197. ITALY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. ITALY DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 213. NORWAY DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 214. NORWAY DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NORWAY DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 217. POLAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 219. POLAND DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 220. POLAND DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 221. POLAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 223. QATAR DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 225. QATAR DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 226. QATAR DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 227. QATAR DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. QATAR DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 247. SPAIN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 249. SPAIN DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 250. SPAIN DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SPAIN DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 267. TURKEY DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 268. TURKEY DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. TURKEY DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM DRY EYE MEDICATION MARKET SIZE, BY USER PROFILE, 2018-2030 (USD MILLION)
TABLE 283. DRY EYE MEDICATION MARKET SHARE, BY KEY PLAYER, 2024
TABLE 284. DRY EYE MEDICATION MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dry Eye Medication market report include:
  • AbbVie Inc.
  • Alcon Inc.
  • Astellas Pharma Inc.
  • Bausch + Lomb Corporation
  • EyeGate Pharmaceuticals, Inc.
  • Harrow Health, Inc.
  • Johnson & Johnson Services, Inc.
  • Kala Pharmaceuticals, Inc.
  • Kowa Company, Ltd.
  • Laboratorios Sophia S.A. De C.V.
  • Merck & Co., Inc.
  • Mitotech S.A.
  • Nicox S.A.
  • Novartis AG
  • Ocugen, Inc.
  • Ocular Therapeutix, Inc.
  • Optix Pharmaceuticals, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Perrigo Company plc
  • Pfizer Inc.
  • Rohto Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.
  • Wockhardt Ltd. by Dr. Reddy's Laboratories

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.19 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Dry Eye Medication Market Report 2025 - Product Image

Dry Eye Medication Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Dog Dry Eye Medication Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dog Dry Eye Medication Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Dry Eye Medication Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dry Eye Medication Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Artificial Tears Market by Product Type, Active Ingredient, Distribution Channel, Application Type, Volume Type - Global Forecast to 2030 - Product Image

Artificial Tears Market by Product Type, Active Ingredient, Distribution Channel, Application Type, Volume Type - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Cosmeceuticals Market by Product Type, Active Ingredients, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Cosmeceuticals Market by Product Type, Active Ingredients, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.